False Positive Labeling of Prostate Cancer With High Molecular Weight Cytokeratin: p63 a More Specific Immunomarker for Basal Cells

被引:32
作者
Ali, Tehmina Z. [1 ,4 ]
Epstein, Jonathan I. [2 ,3 ]
机构
[1] Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ Hosp, Dept Urol, Baltimore, MD 21231 USA
[3] Johns Hopkins Univ Hosp, Dept Oncol, Baltimore, MD 21231 USA
[4] Univ Maryland, Med Ctr, Dept Pathol, Baltimore, MD 21201 USA
关键词
basal cells; prostate; high molecular weight cytokeratin; prostate adenocarcinoma; p63;
D O I
10.1097/PAS.0b013e31817ce994
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Occasional nonspecific staining of prostate cancer cells with high molecular weight cytokeratin (HMWCK) can lead to false-negative diagnoses. We compared p63 and HMWCK immunostaining to check their specificity for basal cell identification. Out of 6887 prostate cancer cases sent In consultation to one of the authors over 1.5 years. we identified 22 (0.3%) cases with HMWCK labeling of cancer cells., including 20 needle biopsies and 2 transurethral resections of prostate (TURP). Cases were sent in consultation because of the confusing immunostaining pattern, where prostate cancer cells labeled with HMWCK at the outside institutions. In 6 cases. p63 immunostains were also received from the outside institution, whereas in the remaining 16 cases p63 immunohistochemistry was performed at our institution. In 14 cases, we used either an extra destained hematoxylin and eosin slide or a negative control slide for immunohistochemistry with antibodies to p63. and in the 2 remaining cases Submitted unstained slides were used. The Gleason scores were 3+3 = 6 in 20 cases and 4+4 = 8 in 2 cases. The size of the tumor on needle biopsy ranged from 0.5 to 6.0 mm (mean I mm) and on the 2 TURP cases consisted of 44 and 68 cancer glands, respectively. The number of tumor cells positive for HMWCK in each of the needle biopsy cases ranged from 3 to 48 (mean 13 cells), whereas on the 2 TURP cases 26 and 10 cells were labeled with HMWCK. Corresponding stains for p63 on the same cases were negative in 18 cases. In 3 of 4 cases, p63 labeled 1. 1, and 2 tumor cells, respectively. The fourth case had 5 positive cells on p63 staining with 4 positive for HMWCK. To assess whether overstaining was a factor, we evaluated the intensity of HMWCK staining in the basal cells of the benign glands, which was moderate in 6 and strong in 16 cases. The cytoplasm of benign secretory cells showed focal weak (n = 3). diffuse weak (n = 1), and focal moderate (n = 2) staining for HMWCK. HMWCK labeling of prostate cancer cells is uncommon and does not seem to be solely attributable to overstaining. p63 is a more specific marker for basal cells than HMWCK. with less labeling of tumor cells. Recognition of this phenomenon and performing stains for p63 when it occurs can help prevent underdiagnosing prostatic carcinoma.
引用
收藏
页码:1890 / 1895
页数:6
相关论文
共 19 条
[1]   Efficacy of restaining prostate needle biopsies with high-molecular weight cytokeratin [J].
Dardik, M ;
Epstein, JI .
HUMAN PATHOLOGY, 2000, 31 (09) :1155-1161
[2]   Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: Implications for patient care [J].
Epstein, JI ;
Herawi, M .
JOURNAL OF UROLOGY, 2006, 175 (03) :820-834
[3]   Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy [J].
Epstein, JI .
MODERN PATHOLOGY, 2004, 17 (03) :307-315
[4]  
Gaudin P B, 1997, Anat Pathol, V2, P111
[5]   Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma [J].
Googe, PB ;
McGinley, KM ;
Fitzgibbon, JF .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (02) :219-223
[6]   USE OF KERATIN 903 AS AN ADJUNCT IN THE DIAGNOSIS OF PROSTATE CARCINOMA [J].
HEDRICK, L ;
EPSTEIN, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (05) :389-396
[7]   Small glandular proliferations on needle biopsies - Most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion [J].
Herawi, M ;
Parwani, AF ;
Irie, J ;
Epstein, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (07) :874-880
[8]   Prostate-specific antigen, high-molecular-weight cytokeratin (Clone 34βE12), and/or p63 -: An optimal lmmunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma [J].
Kunju, LP ;
Mehra, R ;
Snyder, M ;
Shah, RB .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (05) :675-681
[9]   Can basal cells be seen in adenocarcinoma of the prostate? -: An immunohistochemical study using high molecular weight cytokeratin (clone 34βE12) antibody [J].
Oliai, BR ;
Kahane, H ;
Epstein, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (09) :1151-1160
[10]   USEFULNESS OF IMMUNOPEROXIDASE STAINING WITH HIGH-MOLECULAR-WEIGHT CYTOKERATIN IN THE DIFFERENTIAL-DIAGNOSIS OF SMALL-ACINAR LESIONS OF THE PROSTATE-GLAND [J].
OMALLEY, FP ;
GRIGNON, DJ ;
SHUM, DT .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1990, 417 (03) :191-196